About Treatment
Hemastyl Treatment Covered by Medicare and Insurance Reimbursement
Hemastyl® Gel is eligible for reimbursement under Medicare, Medicaid, and many private insurance plans when used as part of a physician-directed treatment plan for qualifying chronic wounds such as diabetic ulcers, venous leg ulcers, pressure injuries, and other managed wound types. Coverage varies by insurer, but many patients can access Hemastyl® with low or no out-of-pocket cost through their healthcare provider.
Product Information
Key Features
The Hemastyl gel is an FDA-cleared topical formulation designed to support wound closure by improving the local environment needed for tissue repair. Hemastyl® Wound Gel delivers a next-generation wound-care interface designed to optimize tissue hydration, support a clean healing environment, and enhance the effectiveness of wound healing. Unlike generic hydrogels, Hemastyl is purpose-built for the periwound region, a key factor in whether chronic wounds close successfully or progress toward infection and amputation.
99% effective against CANDIDA AURIS
Hydrogel Base for Moist Wound Healing Environment
Amorphous hydrogel formulation supports moisture donation, hydration of wound bed and helps maintain a moist environment conducive to healing. Integrates seamlessly into daily wound-care routines.
Versatile Indications and Wound-type Compatibility
In a feasibility study, Hemastyl prevented 17 amputations and closed 39 total complex wounds. This was accomplished by treating the tissue surrounding the wound, preventing scheduled amputations from ever taking place.
99% effective against CANDIDA AURIS
Proven effective against Candida Auris, a deadly candida organism that is spreading in hospitals around the globe. This organism has been proving to be antibiotic resistant and all current antifungal medications are not effective against this strain, according to the CDC.
Real Case Progressions
Clinical case timelines from real Hemastyl use.
These examples show how Hemastyl has been used in real clinical settings to support healing in challenging wounds. Each timeline reflects the patient’s individual course under physician care. Images are shared with permission.
Science
Common Hemastyl wound gel use in wound care
Pressure injuries: Hemastyl gel can be used with all stages of pressure injuries. Due to its antimicrobial benefits, it is a good option for infected wounds as well as pressure injuries, such as wounds on the tailbone or buttocks.
Venous ulcers: The use of Hemastyl gel on venous stasis ulcers is less common due to the risk of overhydrating the wound and macerating the periwound. Since venous stasis ulcers are commonly higher output wounds, take care when using a wound hydrating treatment.
Arterial ulcers: This ulcer etiology typically has a dryer wound bed with no to minimal drainage. This makes the choice to use Hemastyl gel appropriate for open arterial ulcers. As always, protect and keep stable dry eschar on heels and toes to prevent infection and wound deterioration until a vascular specialist evaluates the patient.
Diabetic wounds: You can use this treatment on neuropathic wounds, such as diabetic foot ulcers, which often have some level of arterial involvement as a secondary cause. With these wounds, be mindful of dry eschar on the heel and toes (like with arterial ulcers) until the patient undergoes a thorough vascular assessment.
Traumatic wounds: Hemastyl gel can be beneficial on traumatic wounds as it can decrease pain in the wound bed. Keeping the wound bed moist with frequent dressing changes and a hydrating gel can decrease pain and make dressing changes a faster and more comfortable process. The antimicrobial preservation property of Hemastyl gel is an added bonus for patients.
Latest News
Read Latest News
This section features updates from our team, insights on product development, and announcements as Hemastyl® progresses through clinical, regulatory, and commercial milestones. Stay connected as we share news, company developments, and future resources designed to support clinicians and patients alike.